Literature DB >> 33154637

Response Surface Methodology for Statistical Optimization of Chitosan/Alginate Nanoparticles as a Vehicle for Recombinant Human Bone Morphogenetic Protein-2 Delivery.

Maryam Zohri1, Hamid Akbari Javar2, Taraneh Gazori3, Mohammad Reza Khoshayand4, Seyed Hamid Aghaee-Bakhtiari5,6, Mohammad Hossein Ghahremani1,7.   

Abstract

PURPOSE: In this study, chitosan/alginate nanoparticles are prospected as a carrier for controlled release of recombinant human bone morphogenetic protein-2 (rhBMP-2).
MATERIALS AND METHODS: The rhBMP-2-loaded chitosan/alginate nanoparticles (Cs/Alg/B NPs) were prepared using the ionic gelation (IG) method. The current research was conducted to optimize the effective factors for entrapping rhBMP-2 in Cs/Alg NPs using response surface methodology (RSM) and the Box-Behnken design (BBD). The variables were the Cs/Alg molecular weight (Mw) ratios (1-3), pH (4.8-5.5), stirring rates (900-1300 rpm) and the responses included size, ζ-potential, polydispersity index (PDI), loading efficacy (LE), cumulative release (CR), and morphological degradation time (MDE). Then, the morphological properties of optimum formulation were studied for post-characterization. In the next step, the MTT assay for the optimized run was done for 24 and 48 hours.
RESULTS: The results revealed that the optimum conditions for the mentioned variables were stirring rate=1100 rpm, pH=5.15, and Cs/Alg Mw ratio=1.75 based on numerical optimization. It was shown that the average particle size and loading efficacy at optimum conditions were 253 nm and 67%, respectively. Other responses were as follows: CR=66%, ζ-potential=+35mV, PDI=0.5, and MDT=7 days.
CONCLUSION: The results have suggested that the statistical optimization of rhBMP-2 offers the possibility of preparing Cs/Alg/B NPs with a favorable size, controlled release characteristics, and high loading efficiency. It is expected that the acquired optimum conditions will be useful for efficient rhBMP-2 delivery.
© 2020 Zohri et al.

Entities:  

Keywords:  Box–Behnken design(BBD); alginate; chitosan; chitosan/alginate nanoparticles; recombinant human bone morphogenetic protein-2 (rhBMP-2); response surface methodology (RSM)

Mesh:

Substances:

Year:  2020        PMID: 33154637      PMCID: PMC7606360          DOI: 10.2147/IJN.S250630

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  35 in total

Review 1.  Current applications of nanoparticles in infectious diseases.

Authors:  Hinojal Zazo; Clara I Colino; José M Lanao
Journal:  J Control Release       Date:  2016-01-06       Impact factor: 9.776

2.  Effects of process variables on micromeritic properties and drug release of non-degradable microparticles.

Authors:  Mitra Jelvehgari; Jaleh Barar; Ali Nokhodchi; Sanam Shadrou; Hadi Valizadeh
Journal:  Adv Pharm Bull       Date:  2011-07-30

3.  Calcium phosphate-DNA nanoparticle gene delivery from alginate hydrogels induces in vivo osteogenesis.

Authors:  Melissa D Krebs; Erin Salter; Eric Chen; Kathleen A Sutter; Eben Alsberg
Journal:  J Biomed Mater Res A       Date:  2010-03-01       Impact factor: 4.396

4.  Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study.

Authors:  Syed Sarim Imam; Mohammed Aqil; Mohammed Akhtar; Yasmin Sultana; Asgar Ali
Journal:  Drug Deliv       Date:  2014-01-29       Impact factor: 6.419

5.  Effect of rhBMP-2 sustained-release nanocapsules on the ectopic osteogenesis process in Sprague-Dawley rats.

Authors:  Ren-Fa Lai; Ze-Jian Li; Zhi-Ying Zhou; Zhi-Qiang Feng; Qing-Tong Zhao
Journal:  Asian Pac J Trop Med       Date:  2013-11       Impact factor: 1.226

Review 6.  The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles.

Authors:  Eleonore Fröhlich
Journal:  Int J Nanomedicine       Date:  2012-11-02

7.  Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [(14)C]-doxorubicin.

Authors:  Mas Jaffri Masarudin; Suzanne M Cutts; Benny J Evison; Don R Phillips; Paul J Pigram
Journal:  Nanotechnol Sci Appl       Date:  2015-12-11

Review 8.  Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration.

Authors:  Inas El Bialy; Wim Jiskoot; M Reza Nejadnik
Journal:  Pharm Res       Date:  2017-03-24       Impact factor: 4.200

Review 9.  Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties.

Authors:  Alyona Sukhanova; Svetlana Bozrova; Pavel Sokolov; Mikhail Berestovoy; Alexander Karaulov; Igor Nabiev
Journal:  Nanoscale Res Lett       Date:  2018-02-07       Impact factor: 4.703

10.  Efficient delivery of recombinant human bone morphogenetic protein (rhBMP-2) with dextran sulfate-chitosan microspheres.

Authors:  Yuan-Jun Xia; Hong Xia; Ling Chen; Qing-Shui Ying; Xiang Yu; Li-Hua Li; Jian-Hua Wang; Ying Zhang
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.